Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
President, Chief Executive Officer, Co-Founder, Director | Apellis Pharmaceuticals Inc | 1 janvier 2016 - |
President, Chief Executive Officer, Director | Apellis Pharmaceuticals Inc | 1 septembre 2009 - 1 janvier 2016 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
3 962
-1.2%
67,77268 492 USD |
3 962 -1.2% | 67,77 | 268 492 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
2 843
-0.9%
64,14182 345 USD |
2 843 -0.9% | 64,14 | 182 345 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
13 431
-4.0%
65,00872 961 USD |
13 431 -4.0% | 65,00 | 872 961 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
7 851
-2.3%
66,81524 514 USD |
7 851 -2.3% | 66,81 | 524 514 USD | |
2023-11-21 | 2023-11-21 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
5 000
-1.8%
48,80244 000 USD |
5 000 -1.8% | 48,80 | 244 000 USD | |
2023-09-01 | 2023-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
10 284
-2.4%
42,44436 453 USD |
10 284 -2.4% | 42,44 | 436 453 USD | |
2023-09-01 | 2023-09-01 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
139 716
-24.3%
41,705 826 506 USD |
139 716 -24.3% | 41,70 | 5 826 506 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 120
-0.8%
87,67185 869 USD |
2 120 -0.8% | 87,67 | 185 869 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
7 528
-2.6%
87,02655 059 USD |
7 528 -2.6% | 87,02 | 655 059 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
3 007
-1.0%
85,90258 305 USD |
3 007 -1.0% | 85,90 | 258 305 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
14 611
-4.8%
85,011 242 065 USD |
14 611 -4.8% | 85,01 | 1 242 065 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 800
-0.6%
83,85150 921 USD |
1 800 -0.6% | 83,85 | 150 921 USD | |
2023-05-18 | 2023-05-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
934
-0.3%
83,1777 682 USD |
934 -0.3% | 83,17 | 77 682 USD | |
2023-04-20 | 2023-04-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
30 000
-4.5%
82,022 460 720 USD |
30 000 -4.5% | 82,02 | 2 460 720 USD | |
2022-12-21 | 2022-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
24 449
-2.5%
52,071 273 052 USD |
24 449 -2.5% | 52,07 | 1 273 052 USD | |
2020-12-16 | 2020-12-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.4%
52,16260 800 USD |
5 000 -0.4% | 52,16 | 260 800 USD | |
2020-11-17 | 2020-11-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
39,38196 900 USD |
5 000 -0.5% | 39,38 | 196 900 USD | |
2020-10-16 | 2020-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
34,46172 300 USD |
5 000 -0.5% | 34,46 | 172 300 USD | |
2020-09-16 | 2020-09-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
30,96154 800 USD |
5 000 -0.5% | 30,96 | 154 800 USD | |
2020-08-21 | 2020-08-20 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
3 457
-0.3%
30,00103 710 USD |
3 457 -0.3% | 30,00 | 103 710 USD | |
2020-08-20 | 2020-08-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 543
-0.1%
30,0046 290 USD |
1 543 -0.1% | 30,00 | 46 290 USD | |
2020-07-16 | 2020-07-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
32,12160 600 USD |
5 000 -0.5% | 32,12 | 160 600 USD | |
2020-06-16 | 2020-06-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
30,21151 050 USD |
5 000 -0.5% | 30,21 | 151 050 USD | |
2020-05-19 | 2020-05-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.4%
29,92149 600 USD |
5 000 -0.4% | 29,92 | 149 600 USD | |
2020-04-17 | 2020-04-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.4%
29,77148 850 USD |
5 000 -0.4% | 29,77 | 148 850 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
300
-0.0%
23,867 158 USD |
300 -0.0% | 23,86 | 7 158 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
3 212
-0.3%
22,2871 557 USD |
3 212 -0.3% | 22,28 | 71 557 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
15 065
-1.4%
21,58325 088 USD |
15 065 -1.4% | 21,58 | 325 088 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
12 060
-1.1%
20,69249 558 USD |
12 060 -1.1% | 20,69 | 249 558 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
700
-0.1%
22,2915 600 USD |
700 -0.1% | 22,29 | 15 600 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 192
-0.2%
21,5747 279 USD |
2 192 -0.2% | 21,57 | 47 279 USD | |
2020-03-18 | 2020-03-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
2 108
-0.2%
20,7343 695 USD |
2 108 -0.2% | 20,73 | 43 695 USD | |
2020-02-20 | 2020-02-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
40,67203 330 USD |
5 000 -0.5% | 40,67 | 203 330 USD | |
2020-02-20 | 2020-02-18 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
30 637
-2.9%
40,661 245 792 USD |
30 637 -2.9% | 40,66 | 1 245 792 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-0.5%
41,47207 350 USD |
5 000 -0.5% | 41,47 | 207 350 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
4 562
-0.5%
42,55194 099 USD |
4 562 -0.5% | 42,55 | 194 099 USD | |
2020-01-17 | 2020-01-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
26 076
-2.5%
42,161 099 338 USD |
26 076 -2.5% | 42,16 | 1 099 338 USD | |
2019-10-16 | 2019-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
3 524
-0.3%
26,6193 784 USD |
3 524 -0.3% | 26,61 | 93 784 USD | |
2019-10-16 | 2019-10-15 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
1 476
-0.1%
25,5937 766 USD |
1 476 -0.1% | 25,59 | 37 766 USD | |
2019-09-17 | 2019-09-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
260
-0.0%
27,177 064 USD |
260 -0.0% | 27,17 | 7 064 USD | |
2019-09-17 | 2019-09-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
4 740
-0.5%
26,56125 885 USD |
4 740 -0.5% | 26,56 | 125 885 USD |